ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
400 Dose-dense sequential adriamycin-paclitaxel-cyclophosphamide (A-T-C) chemotherapy in high-risk early breast cancer — a phase II study
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(03)90432-0
◽
2003
◽
Vol 1
(5)
◽
pp. S122
Author(s):
Z. Kahán
◽
G. Uhercsák
◽
R. Hajnal-Papp
◽
K. Boda
◽
L. Thurzó
Keyword(s):
Breast Cancer
◽
High Risk
◽
Early Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Dose Dense
Download Full-text
Related Documents
Cited By
References
Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.537
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 537-537
Author(s):
Francesco Recchia
◽
Giampiero Candeloro
◽
Alisia Cesta
◽
Stefano Necozione
◽
Silvio Rea
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Early Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Long Term Follow Up
Download Full-text
2083 POSTER Adjuvant delivery of a dose-dense, sequential FEC-docetaxel regimen to patients with high-risk breast cancer is feasible – results of a randomized, open-label Phase II study
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(07)70845-5
◽
2007
◽
Vol 5
(4)
◽
pp. 208
Author(s):
H. Wildiers
◽
L. Dirix
◽
P. Neven
◽
A. Prové
◽
P. Clement
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Phase Ii
◽
Phase Ii Study
◽
Open Label
◽
Open Label Phase
◽
Dose Dense
◽
High Risk Breast Cancer
◽
High Risk Breast
◽
Risk Breast Cancer
Download Full-text
Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer
Oncology
◽
10.1159/000089991
◽
2005
◽
Vol 69
(5)
◽
pp. 372-383
◽
Cited By ~ 7
Author(s):
Maysa M. Abu-Khalaf
◽
Stephen Windsor
◽
Keita Ebisu
◽
Saritha Salikooti
◽
Gowri Ananthanarayanan
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Phase Ii
◽
Phase Ii Study
◽
Dose Dense
◽
High Risk Breast Cancer
◽
High Risk Breast
◽
Risk Breast Cancer
Download Full-text
Phase II Study of Feasibility of Dose-Dense FEC Followed by Alternating Weekly Taxanes in High-Risk, Four or More Node-Positive Breast Cancer
Breast Diseases A Year Book Quarterly
◽
10.1016/s1043-321x(05)80227-9
◽
2005
◽
Vol 16
(3)
◽
pp. 278
Author(s):
D. Shafer
◽
L.J. Goldstein
Keyword(s):
Breast Cancer
◽
High Risk
◽
Phase Ii
◽
Phase Ii Study
◽
Node Positive
◽
Dose Dense
◽
Positive Breast Cancer
Download Full-text
A phase II study of dose-dense docetaxel and mitoxantrone in the treatment of patients with high-risk metastatic breast cancer
Anti-Cancer Drugs
◽
10.1097/00001813-200209000-00007
◽
2002
◽
Vol 13
(8)
◽
pp. 827-832
◽
Cited By ~ 3
Author(s):
Ellen König
◽
Christian Kurbacher
◽
Martin Schwonzen
◽
Martina Breidenbach
◽
Peter Mallmann
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
High Risk
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Dose Dense
Download Full-text
2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(07)70857-1
◽
2007
◽
Vol 5
(4)
◽
pp. 211-212
◽
Cited By ~ 1
Author(s):
S. Kahan
◽
S. Spanik
◽
M. Wagnerova
◽
T. Skacel
◽
B. Planko
◽
...
Keyword(s):
Breast Cancer
◽
Adjuvant Therapy
◽
Cancer Patients
◽
Early Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Breast Cancer Patients
◽
Open Label
◽
Dose Dense
Download Full-text
Phase II Study of Feasibility of Dose-Dense FEC Followed by Alternating Weekly Taxanes in High-Risk, Four or More Node-Positive Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-04-0634
◽
2004
◽
Vol 10
(17)
◽
pp. 5754-5761
◽
Cited By ~ 26
Author(s):
Chau T. Dang
◽
Gabriella M. D’Andrea
◽
Mary E. Moynahan
◽
Maura N. Dickler
◽
Andrew D. Seidman
◽
...
Keyword(s):
Breast Cancer
◽
High Risk
◽
Phase Ii
◽
Phase Ii Study
◽
Node Positive
◽
Dose Dense
◽
Positive Breast Cancer
Download Full-text
A Prospective, Belgian Multi-center, Single-arm, Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer
Case Medical Research
◽
10.31525/ct1-nct04224922
◽
2020
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Study
◽
Stage Ii
◽
Weekly Paclitaxel
◽
Dose Dense
Download Full-text
Faculty Opinions recommendation of Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.734565867.793581155
◽
2020
◽
Author(s):
David Potter
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Neoadjuvant Therapy
◽
Early Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Estrogen Receptor Positive
Download Full-text
Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence
Annals of Surgical Oncology
◽
10.1245/s10434-019-07350-7
◽
2019
◽
Vol 26
(8)
◽
pp. 2428-2434
◽
Cited By ~ 6
Author(s):
Masataka Sawaki
◽
Takeshi Miyamoto
◽
Tomomi Fujisawa
◽
Yoshiyuki Itoh
◽
Takeshi Ebara
◽
...
Keyword(s):
Breast Cancer
◽
Early Breast Cancer
◽
Phase Ii
◽
Tumor Recurrence
◽
Phase Ii Study
◽
Intraoperative Radiotherapy
◽
Multicenter Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close